• Introduction Human Health Animal Health PR Center Customer Center
    • Introduction
    • Chairman Greeting
    • Introduction
    • Vision
    • History
    • CI
    • Location
    • Human Health
    • Pharmaceutical Division
    • Project
    • Production Facilities
    • R&D
    • Library
    • Animal Health
    • Animal Health Division
    • Product
    • Laboratory Institute
    • PR Center
    • Komipharm News
    • Archive
    • PR Video
    • E-Brochure
    • Customer Center
    • Product inquiry
    • Inquiry of
      Rabies Serological Test
    • Other Inquiry
  • Introduction
    • Chairman Greeting
    • Introduction
    • Vision
    • History
    • CI
    • Location
  • Human Health
    • Pharmaceutical Division
    • Project
    • Production Facilities
    • R&D
    • Library
  • Animal Health
    • Animal Health Division
    • Product
    • Laboratory Institute
  • PR Center
    • Komipharm News
    • Archive
    • PR Video
    • E-Brochure
  • Customer Center
    • Product inquiry
    • Inquiry of
      Rabies Serological Test
    • Other Inquiry
ENG
  • KOREAN
  • ENGLISH
SUPPORT

PRODUCTINQUIRY

Representative contact
Tel : +82-70-7166-8727
zeus245@komipharm.com
webmaster@komipharm.com
English-Speaking-Areas
Tel: +82-70-7166-8732
ymkim@komipharm.com
Russian-Speaking-Areas
Tel: +82-70-7166-8729
ahwha6@komipharm.com
Chinese-Speaking-Areas
Tel: +82-70-7166-8740
xinghua@komipharm.com
  • Animal Health Division
  • Product
  • Laboratory Institute
Vaccine Chemicals Aquacultures
  • PRO-VAC APPm
  • Swine255
  • For the prevention of pneumonic pasteurellosis and pleuropneumoniae infection

전체열기 전체닫기

CALSS
INACTIVATED VACCINE
TARGET SPECIES
PIG
ACTIVE INGREDIENT
Inactivated Actinobacillus pleuropneumoniae [A. pleuropneumoniae, type 2] 	
Inactivated Actinobacillus pleuropneumoniae [A. pleuropneumoniae, type 5] 	
 Actinobacillus pleuropneumoniae toxoid [A. pleuropneumoniae, type 2] 	
 Actinobacillus pleuropneumoniae toxoid [A. pleuropneumoniae, type 5] 	
 Inactivated Pastuerella multocida [P. multocida, type D] 	
 Inactivated Pastuerella multocida [P. multocida, type A] 	
 Pastuerella multocida toxoid[P. multocida, type D] 
DOSAGE AND ADMINISTRATION
Route:  I.M. (Intramuscularly)
Vaccination regime:
Sow: 2.0mL/ Dose. 2-shots at 4~5 weeks and 2~3 weeks before parturition
Boar: 2.0mL/ Dose. 2-shots at 2 weeks interval after selection. Booster vaccination can be given at every 6 months.
Piglet born from vaccinated sow: 1.0mL/ Dose. 2-shots at 3~4 weeks and 5~6 weeks after birth
STORAGE
REFRIGERATED
Inactivated Actinobacillus pleuropneumoniae, type 2, type 5, Actinobacillus pleuropneumoniae toxoid, Inactivated Pastuerella multocida, type D, type A, Pastuerella multocida toxoid
  • Introduction Human Health Animal Health PR Center Customer Center
    • Introduction
    • Chairman Greeting
    • Introduction
    • Vision
    • History
    • CI
    • Location
    • Human Health
    • Pharmaceutical Division
    • Project
    • Production Facilities
    • R&D
    • Library
    • Animal Health
    • Animal Health Division
    • Product
    • Laboratory Institute
    • PR Center
    • Komipharm News
    • Archive
    • PR Video
    • E-Brochure
    • Customer Center
    • Product inquiry
    • Inquiry of
      Rabies Serological Test
    • Other Inquiry
  • Introduction
    • Chairman Greeting
    • Introduction
    • Vision
    • History
    • CI
    • Location
  • Human Health
    • Pharmaceutical Division
    • Project
    • Production Facilities
    • R&D
    • Library
  • Animal Health
    • Animal Health Division
    • Product
    • Laboratory Institute
  • PR Center
    • Komipharm News
    • Archive
    • PR Video
    • E-Brochure
  • Customer Center
    • Product inquiry
    • Inquiry of
      Rabies Serological Test
    • Other Inquiry
Menu
  • Introduction
  • Human health
  • Animal health
  • PR Center
  • Customer center
Head Office
  • 17, Gyeongje-Ro, Siheung-Si, Gyeonggi-Do, South Korea
Plant
  • 17, Gyeongje-Ro, Siheung-Si, Gyeonggi-Do, South Korea
  • 235-24, Chusa-Ro, Sinam-Myeon, Yesan-Gun, Chungcheongnam-Do, South Korea
  • 291, Osonggarak- Ro, Osong-Eup, Cheongwon-Gun, Chungcheonbuk-Do
Contact
  • +82-31-498-6104
  • +82-31-498-2120
  • webmaster@komipharm.com
Menu
  • INTRODUCTION
  • PHARMACEUTICAL
  • ANIMAL HEALTH
  • IR
  • PR CENTER
Head Office
  • 17, Gyeongje-Ro, Siheung-Si, Gyeonggi-Do, South Korea
Plant
  • 17, Gyeongje-Ro, Siheung-Si, Gyeonggi-Do, South Korea
  • 235-24, Chusa-Ro, Sinam-Myeon, Yesan-Gun, Chungcheongnam-Do, South Korea
  • 291, Osonggarak- Ro, Osong-Eup, Cheongwon-Gun, Chungcheonbuk-Do
Contact
  • +82-31-498-6104
  • +82-31-498-2120
  • webmaster@komipharm.com
  • Unauthorized Collection of E-mail
  • Privacy Notice
  • Investment Regulations
  • Code of Ethics

Copyright @ komipharm. All Rights Reserved.

    Unauthorized Collection of E-mail Privacy Notice Investment Regulations Code of Ethics

Copyright @ komipharm. All Rights Reserved.